Cargando…

Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma

Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromocriptine. Transsphenoidal pituitary adenoma resection was done with normali...

Descripción completa

Detalles Bibliográficos
Autores principales: Menon, Lakshmi P., Rahman, Wedad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261848/
https://www.ncbi.nlm.nih.gov/pubmed/34218714
http://dx.doi.org/10.1177/23247096211029750
_version_ 1783719081881370624
author Menon, Lakshmi P.
Rahman, Wedad
author_facet Menon, Lakshmi P.
Rahman, Wedad
author_sort Menon, Lakshmi P.
collection PubMed
description Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromocriptine. Transsphenoidal pituitary adenoma resection was done with normalization of the prolactin level. Priapism is a rare side effect of dopamine agonists that warrants discontinuation of therapy. Patients should be educated about this potential side effect at the time of prescribing the medication.
format Online
Article
Text
id pubmed-8261848
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-82618482021-07-19 Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma Menon, Lakshmi P. Rahman, Wedad J Investig Med High Impact Case Rep Case Report Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromocriptine. Transsphenoidal pituitary adenoma resection was done with normalization of the prolactin level. Priapism is a rare side effect of dopamine agonists that warrants discontinuation of therapy. Patients should be educated about this potential side effect at the time of prescribing the medication. SAGE Publications 2021-07-05 /pmc/articles/PMC8261848/ /pubmed/34218714 http://dx.doi.org/10.1177/23247096211029750 Text en © 2021 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Menon, Lakshmi P.
Rahman, Wedad
Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
title Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
title_full Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
title_fullStr Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
title_full_unstemmed Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
title_short Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
title_sort recurrent priapism from cabergoline and bromocriptine in a hypogonadal man with prolactinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261848/
https://www.ncbi.nlm.nih.gov/pubmed/34218714
http://dx.doi.org/10.1177/23247096211029750
work_keys_str_mv AT menonlakshmip recurrentpriapismfromcabergolineandbromocriptineinahypogonadalmanwithprolactinoma
AT rahmanwedad recurrentpriapismfromcabergolineandbromocriptineinahypogonadalmanwithprolactinoma